Adam Jason Khorasanchi MD
Hospital Medicine/Hospitalist
Physician at The Ohio State University Wexner Medical Center
Join to View Full Profile
410 W 10th AveColumbus, OH 43210
Dr. Khorasanchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Adam Khorasanchi, MD, is an internal medicine specialist located in Columbus, OH, with a subspecialty in hospital medicine. He completed his residency in internal medicine at Stony Brook Medicine/University Hospital in 2020 after graduating from the State University of New York Downstate Medical Center College of Medicine in 2017. Dr. Khorasanchi is currently practicing as a physician at The Ohio State University Wexner Medical Center and The OSUCCC - James, having previously worked as a hospitalist at VCU Medical Center. His experience encompasses oncology and hospital medicine. He has authored several publications on topics such as genitourinary malignancies, renal cell carcinoma, non-small cell lung cancer, and melatonin supplementation for cancer-related fatigue, with some of his work being cited by other researchers.
Education & Training
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2017 - 2020
State University of New York Downstate Medical Center College of MedicineClass of 2017
Certifications & Licensure
OH State Medical License 2022 - 2026
VA State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.Alexander Rudich, Natalie Johns, Songzhu Zhao, Kenneth Chian, Po-Lan Su
Journal of the National Comprehensive Cancer Network. 2025-03-28 - CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.Natalie Johns, Alexander Rudich, Songzhu Zhao, Kenneth Chian, Po-Lan Su
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.Adam Khorasanchi, Feng Hong, Yuanquan Yang, Eric A Singer, Peng Wang
Cancer Drug Resistance. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
